Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers

This study has been completed.
Information provided by:
Xenon Pharmaceuticals Inc. Identifier:
First received: December 19, 2008
Last updated: September 10, 2009
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)